Safety Considerations with Niacin Therapy

This publication has 49 references indexed in Scilit:

• Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acid treatment
  International Journal Of Clinical Practice, 2006
• Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia
  Published by Elsevier ,2000
• Extended-Release Niacin vs Gemfibrozil for the Treatment of Low Levels of High-Density Lipoprotein Cholesterol
  Archives of internal medicine (1960), 2000
• Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia
  Metabolism, 1998
• Treatment Effect of Niaspan, a Controlled-release Niacin, in Patients with Hypercholesterolemia: A Placebo-controlled Trial
  Journal of Cardiovascular Pharmacology and Therapeutics, 1996
• The prevalence of side effects with regular and sustained-release nicotinic acid
  The American Journal of Medicine, 1995
• Identification of Skin as a Major Site on Prostaglandin D2 Release Following Oral Administration of Niacin in Humans
  Journal of Investigative Dermatology, 1992
• Tolerance to nicotinic acid flushing
  Clinical Pharmacology & Therapeutics, 1991
• Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacin
  Metabolism, 1985
• Clofibrate and Niacin in Coronary Heart Disease
  JAMA, 1975